Research ArticleOsteoarthritis
Open Access
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee
Philip G. Conaghan, Robert H. Dworkin, Thomas J. Schnitzer, Francis Berenbaum, Andrew G. Bushmakin, Joseph C. Cappelleri, Lars Viktrup and Lucy Abraham
The Journal of Rheumatology June 2022, 49 (6) 615-621; DOI: https://doi.org/10.3899/jrheum.210543
Philip G. Conaghan
1P.G. Conaghan, MB BS, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, UK;
Robert H. Dworkin
2R.H. Dworkin, PhD, University of Rochester, Rochester, New York, USA;
Thomas J. Schnitzer
3T.J. Schnitzer, MD, PhD, Northwestern University, Evanston, Illinois, USA;
Francis Berenbaum
4F. Berenbaum, MD, PhD, Sorbonne Université, Paris, France;
Andrew G. Bushmakin
5A.G. Bushmakin, MS, J.C. Cappelleri, PhD, Pfizer Inc, Groton, Connecticut, USA;
Joseph C. Cappelleri
5A.G. Bushmakin, MS, J.C. Cappelleri, PhD, Pfizer Inc, Groton, Connecticut, USA;
Lars Viktrup
6L. Viktrup, MD, PhD, Eli Lilly and Co., Indianapolis, Indiana, USA;
Lucy Abraham
7L. Abraham, MSc, CPsychol, Pfizer Ltd, Surrey, UK.
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- Guyatt GH,
- Juniper EF,
- Walter SD,
- Griffith LE,
- Goldstein RS.
- 7.↵
- U.S. Food and Drug Administration
- 8.↵
- 9.↵
- 10.↵
- Doganay Erdogan B,
- Leung YY,
- Pohl C,
- Tennant A,
- Conaghan PG.
- 11.↵
- 12.↵
- 13.↵
- Schnitzer TJ,
- Easton R,
- Pang S, et al.
- 14.↵
- Berenbaum F,
- Blanco FJ,
- Guermazi A, et al.
- 15.↵
- Hochberg MC,
- Carrino JA,
- Schnitzer TJ, et al.
- 16.↵
- Bellamy N.
- 17.↵
- Cappelleri JC,
- Zou KH,
- Bushmakin AG,
- Alvir JMJ,
- Alemayehu D,
- Symonds T.
- 18.↵
- Fairclough DL.
- 19.↵
- Fitzmaurice GM,
- Laird NM,
- Ware JH.
- 20.↵
- 21.↵
- 22.↵
- 23.↵
- Dworkin RH.
- 24.↵
- Tubach F,
- Ravaud P,
- Baron G, et al.
- 25.↵
In this issue
The Journal of Rheumatology
Vol. 49, Issue 6
1 Jun 2022
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee
Philip G. Conaghan, Robert H. Dworkin, Thomas J. Schnitzer, Francis Berenbaum, Andrew G. Bushmakin, Joseph C. Cappelleri, Lars Viktrup, Lucy Abraham
The Journal of Rheumatology Jun 2022, 49 (6) 615-621; DOI: 10.3899/jrheum.210543
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee
Philip G. Conaghan, Robert H. Dworkin, Thomas J. Schnitzer, Francis Berenbaum, Andrew G. Bushmakin, Joseph C. Cappelleri, Lars Viktrup, Lucy Abraham
The Journal of Rheumatology Jun 2022, 49 (6) 615-621; DOI: 10.3899/jrheum.210543